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Abstract
Apolipoprotein (apo) E-deficient mice were fed a hypercholesterolemic diet for 14 weeks. Mean serum cholesterol 
levels rose to 37.5 mM. Upon complete necroscopy, massive xanthomatous lesions were noticed in various tissues, with 
a predilection for subcutaneous and peritendinous tissues, while control animals on the same diet (3.4 mM serum cho­
lesterol) and apo E-deficient mice on a regular chow diet (20 mM serum cholesterol) did not show such lesions. Also, 
apo E3-Leiden transgenic mice fed a high fat diet, with 60 mM of serum cholesterol, did not exhibit any xanthomatosis. 
The xanthomatous lesions found in the Apoe knock-out mouse clearly differed in location from xanthomas previously 
found in low density lipoprotein receptor-deficient mice. We conclude that the lack of apo E results in atypical dis­
seminated xanthomatosis, suggesting that apo E has an important role in determining the tissue distribution of choles­
terol deposition.
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1. Introduction
Familial dysbetalipoproteinemia (FD), or type 
III hyperlipoproteinemia, is a genetic disorder of 
lipoprotein metabolism predisposing to premature 
atherosclerosis. FD is defined by high levels of 
plasma cholesterol and triglyceride, due to the ac-
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chylomicron and very
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lipoprotein (VLDL) remnants [1]. The primary 
metabolic defect of FD is mostly the presence of 
mutant forms of apolipoprotein (apo) E, resulting 
in a disturbed receptor-mediated clearance of lipo­
protein remnants by the liver [2]. In addition, FD 
may also occur as a consequence of a complete
lack of apo E [3-6].
Recently, two types of mouse models for FD 
have been generated [7-11]. One model comprises
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conventional transgenic mice, overexpressing a 
mutant form of human apo E, which in man causes 
a dominantly inherited form of the disease [7,8]. 
Both the apo E3-Leiden and the apo E (Cys 
112—Arg; Arg 142—Cys) transgenic mice display
increased levels of cholesterol and triglyceride in 
the serum VLDL and low density lipoprotein 
(LDL) fractions. The other model for FD 
represents knock-out mice with a true null muta­
tion in the endogenous mouse Apoe gene [9-11]. 
These apo E-deficient mice show a much more se­
vere phenotype than the transgenics, with high 
plasma cholesterol levels, even when fed a chow 
diet. Diet-induced hypercholesterolemia and ath­
erosclerosis have been described for both FD 
models [12-14].
The occurrence of xanthomas, an accumulation 
of fat-laden histiocytes in various tissues, forms a 
major clinical feature of hyperlipoproteinemia in 
general. More specifically, about 50% of patients 
with FD display tuberous xanthomas on the 
elbows and/or yellowish lipid deposits in the 
creases of the palms of the hands, the so-called 
xanthomata striata palmaris. Both kinds of xan­
thomas are pathognomonic for FD [15]. In addi­
tion, tendinous lesions are sometimes observed in
FD patients.
Familial hypercholesterolemia (FH), which is 
characterized by an elevated plasma LDL-choles- 
terol level, due to a defective LDL receptor 
(LDLR), is often accompanied by typical ten­
dinous xanthomas in the achilles tendon and in the
extender tendons of the hands. Recently, Ishibashi 
et al. showed similar grossly observable xanthoma 
formation in cholesterol-fed LDLR-negative mice, 
demonstrating that mice are also able to develop 
xanthomas [16]. In contrast, the appearance of 
xanthomas has not been described so far in mice 
lacking apo E.
Here we report that, on histologic examination,
apo E-deficient mice fed a hypercholesterolemic diet 
for 14 weeks do develop massive xanthomatosis in 
all kinds of tissues, with a predilection for subcu­
taneous and peritendinous tissue. On the 
macroscopic level, xanthomas could only be 
observed after a much longer (6.5 months) dietary 
treatment. We hypothesize that the lack of apo E 
results in early atypical cholesterol deposition, sug­
gesting that apo E serves an important role in deter­
mining the tissue distribution of xanthomatosis.
2. Methods
2.1. Mice
Apo E-deficient mice were created by 
homologous recombination in embryonic stem cells 
as described [9] and were hybrids between the 
C57BL/6 and 129 Sv strains. C57BL/6 mice were 
used as controls. Apo E3-Leiden transgenic mice 
from the high expressor line #181 had previously 
been generated [7]. Experiments were performed 
with males only. Mice were bred and housed under 
standard conditions in the transgenic animal 
facilities of the Medical Faculty in Nijmegen (Apoe
knockouts) and Leiden (controls and apo E3-Leiden 
transgenic mice).
2.2. Diet
Mice were allowed access to food and water ad 
libitum. The following diets were used, (a) A regu­
lar breeding chow diet (RMH-B) containing 6.2% 
fat. (b) A mild high fat/cholesterol (HFC) diet con­
taining 15% cocoa butter, 0.25% cholesterol, 40.5% 
sucrose, 10% cornstarch, 1 % corn oil, and 6% cellu­
lose. (c) A severe high fat/cholesterol diet 
(HFCO.5%) containing 15% cocoa butter, 1% cho­
lesterol, 0.5% cholate, 40.5% sucrose, 10% cor­
nstarch, 1% corn oil, and 4.7% cellulose (all 
percentages are by weight). The semi-synthetic diets 
HFC and HFCO.5% were composed essentially ac­
cording to [ 17]. All diets were purchased from Hope 
Farms, Woerden, The Netherlands.
2.3. Histological analysis
Mice were sacrificed at 6-7 months of age, after 
14 weeks of diet feeding. Complete necroscopy in­
cluding microscopic examination was performed. 
Tissues were fixed in 10% neutral-buffered formal­
in, processed and embedded in paraffin. Three- 
micrometre sections were routinely stained with 
hematoxylin-phloxine-saffron (HPS).
3. Results
Apo E-deficient mice and controls were fed a mild 
hypercholesterolemic diet (HFC) for 14 weeks.
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Thereafter, four null mutants and two controls were 
sacrificed and a complete necroscopy was perform­
ed . Mean serum cholesterol levels were 37.5 mM 
and 3.4 mM, respectively. Massive xanthomatosis 
W a s observed in various tissues in all four apo E- 
deficient mice after cholesterol feeding as describ­
ed  below, while no xanthomas could be observed 
in  controls on the same diet (Fig. 1).
Extensive xanthomatous lesions were observed in 
the skin (compare Fig. 1A fpr controls with Fig. IB 
for apo E-deficient mice; arrowheads indicate early 
lesions) and subcutaneous tissues, extending into the 
salivary glands (Fig. 1C). Lesions were also seen in 
thyroid glands, muscles, periosteum and upper 
mediastinum, including thymus (not shown). Fig. 
1D shows a higher magnification of a xanthomatous 
lesion of the skin, with cholesterol clefts (ar­
rowheads), multinucleated giant cells (short arrow) 
and necrosis (long arrow). Furthermore, xan­
thomatous lesions were found in periarticular and 
peritendinous tissues (Fig. 1E, arrows) as well as in 
the submucosa of esophagus and forestomach (see 
Figs. IF and 1G for normal and mutant fore­
stomach, respectively; note the broadened sub- 
mucosa in the null mutant). Remarkably, the lesions 
abruptly stopped at the transition from squamous 
epithelium to glandular epithelium (Fig. 1H).
Locations with mild xanthomatous lesions were 
found in the mesothelium of the bladder and kid­
ney, and in the nasal mucosa (not shown). In the 
brain, lesions were present at the origin of the cho-
arrowhead)
of the 11, arrow) and
meninges
many giant cells and
of lymph
observed
Similarly, two age-matched apo E-deficient mice 
on chow (serum cholesterol level of 20 mM) and 
three high expressor apo E3-Leiden transgenic mice,
fed a severe hypercholesterolemic diet (HFC 0.5%) 
for 14 weeks (serum cholesterol level of 60 mM) 
[12], were studied. Neither microscopic nor 
macroscopic analysis could reveal any xanthomas 
in these animals.
So far, all xanthomatous lesions in apo E- 
deficient mice were observed after histological anal­
ysis. After 14 weeks on the HFC diet, there were
no signs of macroscopic xanthoma formation. To 
investigate whether these mice could also develop 
grossly visible xanthomas, a group of 30 homozy­
gous mutant mice and 30 wild-type littermates were
fed the HFC diet for a prolonged time. About one 






This paper demonstrates that apo E-deficient 
mice fed a hypercholesterolemic diet for 14 weeks 
develop severe xanthomatosis. The xanthomatous 
lesions were identified by histological analysis, and
showed a predilection for subcutaneous and periten­
dinous tissues, although more atypical locations 
were also commonly observed. The process of xan­
thoma formation seemed to start at different 
unrelated locations, such as the skin, especially near 
the musculus carnosus, in the peritendinous and 
periarticular tissues, in the submucosa of the 
esophagus and forestomach, and in brain and men­
inges. Strikingly, at the transition from the fore­
stomach lined by squamous epithelium to the 
glandular stomach, the lesions abruptly stopped (see 
Fig. 1H): whether this intriguing finding might be
due to differences in cholesterol homeostasis in the 
histiocytes in these two gastric mucosal locations 
is subject to further investigation. Many other tis­
sues were affected, yet some major organs of the 
reticuloendothelial system such as liver and spleen 
displayed no abnormalities. Severe atherosclerotic 
lesions were present in the aorta and in the pulmo­
nary and carotid arteries, as extensively reported by
others [13,14].
After 14 weeks of dietary treatment, only micro­
scopic, though extensive, xanthomatous lesions 
could be observed in the apo E-deficient mice, with 
no gross signs of xanthomatosis. Absence of gross 
abnormalities in apoe null mutants, after being fed 
a severe high fat diet for 3 months, was reported 
earlier [16]. However, we found that after feeding 
the mild HFC diet for 6.5 months, about one third 
of the apo E-deficient mice had developed xan­
thomas on the face and/or on the distal part of the
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